These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9076788)

  • 1. Oculinum injection-resistant blepharospasm in young patients.
    Roggenkämper P; Nüssgens Z
    Ophthalmic Plast Reconstr Surg; 1997 Mar; 13(1):73. PubMed ID: 9076788
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of techniques of botulinum toxin injections for blepharospasm and hemifacial spasm.
    Sacramento DRC; Lima A; Maia DP; Cunningham M; Maciel RH; Camargos ST; Cardoso F
    Mov Disord; 2019 Sep; 34(9):1401-1403. PubMed ID: 31251420
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose botulinum toxin a for treatment of blepharospasm and hemifacial spasm.
    Poonyathalang A; Preechawat P; Jamnansiri U
    Jpn J Ophthalmol; 2005; 49(4):327-8. PubMed ID: 16075337
    [No Abstract]   [Full Text] [Related]  

  • 4. Skin cooling before periocular botulinum toxin A injection.
    Linder JS; Edmonson BC; Laquis SJ; Drewry RD; Fleming JC
    Ophthalmic Plast Reconstr Surg; 2002 Nov; 18(6):441-2. PubMed ID: 12439058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results.
    Calace P; Cortese G; Piscopo R; Della Volpe G; Gagliardi V; Magli A; De Berardinis T
    Eur J Ophthalmol; 2003 May; 13(4):331-6. PubMed ID: 12872788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hyperfunctional lines of the face with botulinum toxin A.
    Binder WJ; Blitzer A; Brin MF
    Dermatol Surg; 1998 Nov; 24(11):1198-205. PubMed ID: 9834739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riolan's muscle: action and indications for botulinum toxin injection.
    Mackie IA
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What to do in cases of inadequate effectiveness of botulinum toxin for the treatment of eyelid cramping?].
    Roggenkämper P
    Ophthalmologe; 2007 Sep; 104(9):763-6. PubMed ID: 17726608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
    Cillino S; Raimondi G; Guépratte N; Damiani S; Cillino M; Di Pace F; Casuccio A
    Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Headache and facial pain responsive to botulinum toxin: an unusual presentation of blepharospasm.
    Johnstone SJ; Adler CH
    Headache; 1998 May; 38(5):366-8. PubMed ID: 9630789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm.
    Nüssgens Z; Roggenkämper P
    Graefes Arch Clin Exp Ophthalmol; 1997 Apr; 235(4):197-9. PubMed ID: 9143885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm.
    Truong DD; Gollomp SM; Jankovic J; LeWitt PA; Marx M; Hanschmann A; Fernandez HH;
    J Neural Transm (Vienna); 2013 Sep; 120(9):1345-53. PubMed ID: 23435927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type a and its uses in dry eye disease.
    Victoria AC; Pino A
    Plast Reconstr Surg; 2012 Jul; 130(1):209e-210e. PubMed ID: 22743932
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
    Vargel I; Canter HI; Topaloglu H; Erk Y
    J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of botulinum toxin type a after topical anesthesia.
    Sami MS; Soparkar CN; Patrinely JR; Hollier LM; Hollier LH
    Ophthalmic Plast Reconstr Surg; 2006; 22(6):448-52. PubMed ID: 17117100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin physiology in focal hand and cranial dystonia.
    Karp BI
    Toxins (Basel); 2012 Nov; 4(11):1404-14. PubMed ID: 23202323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized botulism: diagnostic problems in a patient treated with botulinum toxin type A.
    Fota-Markowska H; Mitosek-Szewczyk K; Hasiec T
    Acta Ophthalmol Scand; 2007 Mar; 85(2):231-2. PubMed ID: 17305749
    [No Abstract]   [Full Text] [Related]  

  • 19. Blepharospasm with non-satisfactory response to treatment: our experience with IncobotulinumtoxinA.
    Ricciardi L; Ialongo T; Guidubaldi A; Di Giacopo R; Bentivoglio AR
    Parkinsonism Relat Disord; 2014 Jun; 20(6):665-7. PubMed ID: 24685658
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.